RYMPHYSIA
TAK-883-4002
Approved mab terminated
Quick answer
RYMPHYSIA for Chronic Obstructive Pulmonary Disease (COPD) is a Approved program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Approved
- Modality
- mab
- Status
- terminated